Old Town Scottsdale:
Camelback & 101:

GLP-1 medications have become one of the most effective medical treatments for weight management and metabolic health. These medications are helping patients achieve meaningful, sustained weight loss when combined with proper medical supervision, nutrition guidance, and lifestyle support.
At Phoenix Internal Medicine at Scottsdale, we offer medically supervised GLP-1 weight loss programs designed to help patients improve weight, metabolic health, and long-term wellness.
GLP-1 receptor agonists are medications that help regulate appetite, blood sugar, and digestion. They work by:
Reducing appetite and cravings
Increasing satiety after meals
Improving blood sugar control
Supporting gradual, sustained weight loss
Common medications in this category include semaglutide-based and tirzepatide-based therapies.
GLP-1 therapy may be appropriate for patients who:
Have a BMI in the overweight or obese range
Struggle with weight loss through diet and exercise alone
Have conditions such as prediabetes, type 2 diabetes, or metabolic syndrome
Are seeking medically supervised weight loss options
A full medical evaluation is required before starting treatment.
Our Scottsdale program at Phoenix Internal Medicine at Scottsdale includes:
Initial medical consultation and lab evaluation
Personalized dosing and titration plan
Ongoing follow-up visits to monitor progress and side effects
Nutrition and lifestyle guidance to maximize results
Safety monitoring and long-term maintenance planning
Patients may also experience:
Improved blood sugar control
Lower blood pressure
Reduced cardiovascular risk factors
Improved energy and metabolic health
Our Scottsdale office provides structured, physician-supervised GLP-1 treatment programs focused on safety, consistency, and results. We emphasize medical oversight to ensure appropriate dosing and long-term success.
If you are interested in GLP-1 weight loss treatment in Scottsdale, AZ, schedule a consultation at Phoenix Internal Medicine at Scottsdale to see if you are a candidate.

Author
Phoenix Internal Medicine

June 18, 2026
Scottsdale:
Camelback: